ANGPT1 and diabetes mellitus: Four and 12 weeks after MSC administration, we did not observe differences in the mRNA levels of the pro-angiogenic factors VEGF-α, PDGF and ANG-1 in the eyes of DM + MSC mice compared to untreated DM mice (Fig. 9a).